Patents by Inventor Clemens Gunther
Clemens Gunther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7310569Abstract: Disclosed herein are a method for controlling electronic parcel compartment systems and an interface for carrying out the method. According to the disclosed method, data for controlling the electronic parcel compartment systems are stored on a server and are converted into control commands for controlling the compartment systems. Furthermore, according to the disclosed method, the control commands are transmitted to the parcel compartment systems via an interface.Type: GrantFiled: April 8, 2004Date of Patent: December 18, 2007Assignee: Deutsche Post AGInventors: Boris Mayer, Clemens Günther
-
Publication number: 20070243240Abstract: The invention concerns a transdermal therapeutic system containing ergoline derivatives, preferably lisuride, with a stabilized ergoline compound. Stabilization of the oxidation sensitive ergoline combination is done through a combination of at least one fat-soluble, radical-trapping antioxidant, preferably Di-tert.-butylmethylphenols, Di-tert.-butylmetoxyphenols, tocopherols or ubichinones and a basic polymer. Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy.Type: ApplicationFiled: March 24, 2005Publication date: October 18, 2007Inventors: Fred Windt-Hanke, Clemens Gunther, Reinhard Horowski, Johannes Tack, Adalbert Engfer, Katalin Bostedt, Dirk Schenk
-
Publication number: 20060105030Abstract: The invention concerns a transdermal therapeutic system containing ergoline derivatives, preferably lisuride, with a stabilized ergoline compound. Stabilization of the oxidation sensitive ergoline combination is done through a combination of at least one fat-soluble, radical-trapping antioxidant, preferably Di-tert.-butylmethylphenols, Di-tert.-butylmetoxyphenols, tocopherols or ubichinones and a basic polymer. Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy.Type: ApplicationFiled: March 24, 2005Publication date: May 18, 2006Inventors: Fred Windt-Hanke, Clemens Gunther, Reinhard Horowski, Johannes Tack, Adalbert Engfer, Katalin Bostedt, Dirk Schenk
-
Publication number: 20050220855Abstract: Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy. The invention relates to the use of a transdermal therapeutic system (TTS) comprising a medicinal layer, which contains at least one matrix comprising an active ingredient and/or an active ingredient reservoir and a diffusion barrier situated on the skin side of the active ingredient reservoir and permeable to active ingredients, in addition to, an ergoline-derivative or physiologically compatible salt with an acid thereof, as an active ingredient, for producing a means for treating the restless-legs-syndrome.Type: ApplicationFiled: April 28, 2005Publication date: October 6, 2005Inventors: Reinhard Horowski, Johannes Tack, Fred Windt-Hanke, Clemens Gunther, Adalbert Engfer, Katalin Bostedt, Dirk Schenk
-
Publication number: 20050214353Abstract: Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy. The invention relates to the use of a transdermal therapeutic system (TTS) comprising a medicinal layer, which contains at least one matrix comprising an active ingredient and/or an active ingredient reservoir and a diffusion barrier situated on the skin side of the active ingredient reservoir and permeable to active ingredients, in addition to, an ergoline-derivative or physiologically compatible salt with an acid thereof, as an active ingredient, for producing a means for treating the restless-legs-syndrome.Type: ApplicationFiled: April 28, 2005Publication date: September 29, 2005Inventors: Reinhard Horowski, Johannes Tack, Fred Windt-Hanke, Clemens Gunther, Adalbert Engfer
-
Publication number: 20040260830Abstract: Disclosed herein are a method for controlling electronic parcel compartment systems and an interface for carrying out the method. According to the disclosed method, data for controlling the electronic parcel compartment systems are stored on a server and are converted into control commands for controlling the compartment systems. Furthermore, according to the disclosed method, the control commands are transmitted to the parcel compartment systems via an interface.Type: ApplicationFiled: April 8, 2004Publication date: December 23, 2004Inventors: Boris Mayer, Clemens Gunther
-
Publication number: 20040101550Abstract: Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy.Type: ApplicationFiled: July 7, 2003Publication date: May 27, 2004Inventors: Fred Windt-Hanke, Clemens Gunther, Reinhard Horowski, Johannes Tack
-
Patent number: 6534070Abstract: The invention relates to a pharmaceutical composition having the following constituents: azelaic acid, polyacrylic acid, triacylglyceride, propylene glycol, polysorbate, soya lecithin, water and salts. The composition is a hydrogel which is suited for the treatment of rosacea, presbyderma, melasma or skin irritations.Type: GrantFiled: August 21, 2000Date of Patent: March 18, 2003Assignee: Schering AktiengesellschaftInventors: Patrick Franke, Clemens Günther, Jutta Riedl
-
Publication number: 20030003139Abstract: Matrix-transdermal system that contains (21S)-21-hydroxy-21-methyl-14,17-ethano-19-norpregna-4,9,15-triene-3,20-dione that comprises a polyacrylate adhesive.Type: ApplicationFiled: December 20, 2001Publication date: January 2, 2003Applicant: Schering AGInventors: Ralph Lipp, Clemens Gunther
-
Publication number: 20010009673Abstract: Transderml therapeutic systems are disclosed for the controlled administration of second and third generation gestagenes, and possibly of oestrogens, at least partially dissolved in a matrix. The disclosed systems are characterised in that their matrix contains a copolymer of one or several esters or amides which contain vinyl groups and have the general formula (I), as well as an N-vinyl lactam of general formula (II). In the general formula (I), X symbolises a -COO- group, a -CONH- group or an -OCO- group; R1 stands for a hydrogen atom or an alkyl group with maximum 4 carbon atoms; and R2 stands for a hydrogen atom or an alkyl group with maximum 12 carbon atoms. In the general formula (II), n is a digit from 3 to 5.Type: ApplicationFiled: February 11, 1999Publication date: July 26, 2001Inventors: RALPH LIPP, CLEMENS GUNTHER
-
Patent number: 5904931Abstract: Transdermal therapeutic systems that contain sex steroids and optionally penetration-enhancers and crystallization inhibitors are described, which are characterized in that they contain dimethyl isosorbide, with the exception of systems that contain active ingredient-containing, non-free-flowing gel phases or 3-keto-desogestrel.Type: GrantFiled: November 8, 1996Date of Patent: May 18, 1999Assignee: Schering AktiengesellschaftInventors: Ralph Lipp, Clemens Gunther, Jutta Riedl, Ulrich Tauber
-
Patent number: 5858394Abstract: An agent for transdermal administration is described, which is characterized in that it contains gestodene esters with 1 to 20 carbon atoms in the ester radical optionally in combination with one or two estrogen(s).Type: GrantFiled: May 21, 1996Date of Patent: January 12, 1999Assignee: Schering AktiengesellschaftInventors: Ralph Lipp, Henry Laurent, Clemens Gunther, Jutta Riedl, Peter Esperling, Ulrich Tauber
-
Patent number: 4955698Abstract: An opto-electronic indicating matrix comprises a plurality of row and column segments controllable in a multiplex operation, and means for electrically connecting the row and column segments and including a plurality of conductors arranged in regions between the row segments and inclined to a longitudinal axis of the row axis so as to extend parallel to one another in one plane. A preferable application of the matrix is in an indicator for travel guiding information in a power vehicle.Type: GrantFiled: March 3, 1989Date of Patent: September 11, 1990Assignee: Robert Bosch GmbHInventors: Peter Knoll, Winfried Konig, Rudiger Mock-Hecker, Clemens Gunther